The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 20, 2024

Filed:

Nov. 14, 2022
Applicant:

The Procter & Gamble Company, Cincinnati, OH (US);

Inventors:

Brian Xiaoqing Song, Mason, OH (US);

Brooke Michele Cochran, Cincinnati, OH (US);

Howard David Hutton, III, Oregonia, OH (US);

Andrei Sergeevich Bureiko, Cincinnati, OH (US);

Peter Herbert Koenig, Montgomery, OH (US);

Assignee:

The Procter & Gamble Company, Cincinnati, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/44 (2006.01); A61K 8/73 (2006.01); A61K 8/81 (2006.01); A61Q 5/02 (2006.01); A61Q 5/12 (2006.01); A61K 8/04 (2006.01); A61K 8/46 (2006.01); A61Q 5/00 (2006.01); A61K 8/20 (2006.01); A61K 8/89 (2006.01); A61Q 19/10 (2006.01);
U.S. Cl.
CPC ...
A61K 8/046 (2013.01); A61K 8/20 (2013.01); A61K 8/44 (2013.01); A61K 8/442 (2013.01); A61K 8/466 (2013.01); A61K 8/731 (2013.01); A61K 8/737 (2013.01); A61K 8/817 (2013.01); A61K 8/89 (2013.01); A61Q 5/006 (2013.01); A61Q 5/02 (2013.01); A61Q 5/12 (2013.01); A61Q 19/10 (2013.01); A61K 2800/262 (2013.01); A61K 2800/30 (2013.01); A61K 2800/5426 (2013.01); A61K 2800/596 (2013.01); A61K 2800/87 (2013.01);
Abstract

A clear personal cleansing composition having an anionic surfactant, a cationic deposition polymer, an aqueous carrier and a level of inorganic salt of from about 0 to about 1 wt %. The composition is substantially free of sulfates and has a % T of greater than about 80%. The composition can further comprise amphoteric surfactants. The composition remains phase stable and minimizes coacervate formulation until after dilution with water.


Find Patent Forward Citations

Loading…